Cargando…
Next generation sequencing identifies miRNA-based biomarker panel for lupus nephritis
The symptomatology of lupus nephritis (LN) consists of foamy urine and lower leg edema, as well as such systemic manifestations as oral ulcers, arthralgia/arthritis, and lymphadenopathy. However, these symptoms may appear mild and non-specific. If these symptoms are unrecognized, thus delaying treat...
Autores principales: | Su, Yu-Jih, Lin, I-Chun, Wang, Lin, Lu, Cheng-Hsien, Huang, Yi-Ling, Kuo, Ho-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021342/ https://www.ncbi.nlm.nih.gov/pubmed/29963250 http://dx.doi.org/10.18632/oncotarget.25575 |
Ejemplares similares
-
MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654
por: Tu, Yang, et al.
Publicado: (2019) -
Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis
por: Whittall-Garcia, Laura, et al.
Publicado: (2022) -
Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022) -
Corrigendum: Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022) -
Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
por: Zhou, Xue, et al.
Publicado: (2022)